CLAIM AMENDMENTS IN SOUTH AFRICA JURISDICTION REPORT: SOUTH AFRICA
Dale Verster DM Kisch
In South Africa there is no substantive examination of the claims of a patent application. Once the required formalities of an application have been met, it proceeds to acceptance, publication and grant. Tis leaves a granted South African patent vulnerable to attack by third parties should the claims be incorrectly drawn or should they be too wide in scope in the light of examination in other jurisdictions.
It is therefore advisable to consider amendment of South African claims subsequent to a successful examination in one or more examining jurisdictions. Under the South African Patents Act, a patent may be amended at any time before or aſter grant. However, aſter grant no amendment is allowable if:
Te effect of the amendment would be to introduce new matter or matter not in substance disclosed in the specification before amendment;
Te specification as amended would include any claim not fairly based on matter disclosed in the specification before amendment; and
Te specification as amended includes any claim not wholly within the scope of a claim included in the specification before amendment.
Before acceptance of a patent application, only the first two requirements have to be met.
In the pharmaceutical field, methods of treatment of the human or animal body by surgery or therapy, or of diagnosis practised on the human or animal body are not patentable, nor are claims directed at known compounds for second or subsequent medical indications (purpose limited product claims). A useful expedient to employ with such claims is to convert them to Swiss-style claims.
Such claims were approved in Elan Transdermal v Ciba Geigy (the only decision thus far by a South African court on the question of the validity of known substances for a new subsequent medical use). It was held that in terms of the Patents Act a known substance or composition can be claimed for use in a method of medical treatment only the first time that the substance is disclosed as being useful in medical treatment. A second or subsequent medical use of a known substance is patentable only by way of a Swiss-style claim if the statutory requirements of novelty are met, wherein the novelty would rest in the new medical use.
Te trend in South Africa, as in other countries around the world, is not to expand the scope of protection afforded to patentees for pharmaceutical patents. Consequently, it is unlikely in the future that legislation will be amended to broaden the current protection afforded to patentees for pharmaceutical compounds.
Dale Verster is a patent attorney at DM Kisch. He can be contacted at:
dalev@dmkisch.com
182 World Intellectual Property Review September/October 2013
www.worldipreview.com
“A SECOND OR SUBSEQUENT MEDICAL USE OF A KNOWN SUBSTANCE IS PATENTABLE ONLY BY WAY OF A SWISS- STYLE CLAIM IF THE STATUTORY REQUIREMENTS OF NOVELTY ARE MET.”
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196